These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 32464068

  • 1. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.
    Li S, Li L, Li B, Wang W.
    Br J Radiol; 2020 Aug; 93(1112):20190279. PubMed ID: 32464068
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J, Zheng JP, Shao GL, Wen S, Guo LW, Zeng H, Zhang L, Qian CY, Hao WY.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr 20; 26(4):298-304. PubMed ID: 29996343
    [Abstract] [Full Text] [Related]

  • 3. Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.
    Sun JH, Zhou T, Zhu T, Zhang Y, Nie C, Ai J, Zhou G, Zhang A, Dong MJ, Wang WL, Zheng SS.
    Biomed Res Int; 2016 Apr 20; 2016():3048261. PubMed ID: 27999793
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of transcatheter arterial chemoembolization combined with either 125I seed implantation or apatinib in hepatocellular carcinoma with portal vein tumor thrombosis: A retrospective comparative study.
    Li Y, Li H, Hu H, Yuan H, Zhao Y.
    J Cancer Res Ther; 2020 Apr 20; 16(7):1691-1697. PubMed ID: 33565518
    [Abstract] [Full Text] [Related]

  • 5. [Endovascular implantation of iodine-125 seeds strand and portal vein stenting followed by transcatheter arterial chemoembolization combined therapy with sorafenib for hepatocellular carcinoma with main portal vein tumor thrombus].
    Li WW, Dai ZY, Wan HG, Yao LZ, Zhu J, Li CL, Wang XJ, Pan J, Chen LZ.
    Zhonghua Yi Xue Za Zhi; 2016 Jun 21; 96(23):1838-42. PubMed ID: 27356794
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed.
    Chuan-Xing L, Xu H, Bao-Shan H, Yong L, Pei-Jian S, Xian-Yi Y, Xiao-Ning L, Li-Gong L.
    Cancer Biol Ther; 2011 Nov 15; 12(10):865-71. PubMed ID: 22037354
    [Abstract] [Full Text] [Related]

  • 7. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial.
    Yang M, Fang Z, Yan Z, Luo J, Liu L, Zhang W, Wu L, Ma J, Yang Q, Liu Q.
    J Cancer Res Clin Oncol; 2014 Feb 15; 140(2):211-9. PubMed ID: 24374800
    [Abstract] [Full Text] [Related]

  • 8. Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
    Wang J, Li X, Wang F, Shi D, Zhang J.
    J Cancer Res Ther; 2021 Jul 15; 17(3):619-624. PubMed ID: 34269290
    [Abstract] [Full Text] [Related]

  • 9. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO, Kim BS, Lee CH.
    Clin Mol Hepatol; 2016 Mar 15; 22(1):160-7. PubMed ID: 27044767
    [Abstract] [Full Text] [Related]

  • 10. Endovascular implantation of 125I seed combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
    Sun H, Zhang M, Liu R, Liu Y, Hou Y, Wu C.
    Future Oncol; 2018 May 15; 14(12):1165-1176. PubMed ID: 29334777
    [Abstract] [Full Text] [Related]

  • 11. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP.
    World J Gastroenterol; 2017 Nov 21; 23(43):7735-7745. PubMed ID: 29209114
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis.
    Xu L, Chen S, Cao H, Feng Z, Yang C.
    Acta Pharm; 2024 Sep 01; 74(3):405-422. PubMed ID: 39279524
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Ding X, Sun W, Li W, Shen Y, Guo X, Teng Y, Liu X, Zheng L, Li W, Chen J.
    Cancer; 2021 Oct 15; 127(20):3782-3793. PubMed ID: 34237154
    [Abstract] [Full Text] [Related]

  • 15. A combination of portal vein stent insertion and endovascular iodine-125 seed-strip implantation, followed by transcatheter arterial chemoembolization with sorafenib for treatment of hepatocellular carcinoma-associated portal vein tumor thrombus.
    Li S, Li B, Li L, Xu F, Yang X, Wang W.
    J Contemp Brachytherapy; 2021 Dec 15; 13(6):670-679. PubMed ID: 35079254
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus.
    Pan T, Li XS, Xie QK, Wang JP, Li W, Wu PH, Zhao M.
    Clin Radiol; 2014 Dec 15; 69(12):e553-61. PubMed ID: 25304928
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative study of portal vein stent and TACE combined therapy with or without endovascular implantation of iodine-125 seeds strand for treating patients with hepatocellular carcinoma and main portal vein tumor thrombus].
    Wu LL, Luo JJ, Yan ZP, Wang JH, Wang XL, Zhang XB, Fang ZT, Zhang W.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec 15; 20(12):915-9. PubMed ID: 23522253
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.